Current status of diagnosis and treatment of metastatic liver cancer
Kubo, Y.; Abe, M.; Majima, Y.; Hirai, K.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Pt 1): 590-599
1987
ISSN/ISBN: 0385-0684 PMID: 2435244 Document Number: 294930
Clinical usefulness of liver function tests, tumor markers including CA 19-9, CEA and serum ferritin and image diagnosis was discussed in regard to early diagnosis. Liver function tests were not useful, and tumor markers were highly positive, i.e., CA 19-9 was positive in 70.7% and CEA in 66.7%. However, these were low positive rate, in the early stage. Imaging techniques were very useful in detecting liver metastasis; US positive in 92.5%, CT 87.2% and angiography 93.1%. In the treatment of metastatic liver cancer, arterial chemotherapy and transarterial embolization are the major modality.